Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.92 USD | -8.06% | -2.18% | -51.89% |
May. 01 | UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating | MT |
Apr. 30 | Earnings Flash (TXG) 10X GENOMICS Reports Q1 Revenue $141M, vs. Street Est of $142.1M | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 31.68 | 37.37 | 41.80 |
Spread/Res. | -15.03% | -27.96% | -35.60% |
Spread/Supp. | +0.07% | +0.07% | +5.24% |
Support | 26.90 | 26.90 | 25.58 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- TXG Stock
- Charts 10x Genomics, Inc.